PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis

PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis

Background Despite a series of attempts during the last decades, the prognosis for esophageal squamous cell carcinoma (ESCC) remains poor. Although clinical immunotherapy trials have shown encouraging results, their benefits are limited. This study aims to identify novel targets for immunotherapy in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ning Ma, Wei Chen, Yu Chen, Xiang Wang, Bing Zhu, Kai Ding, Lin Qiu, Jing-jing Li, Jing-Yi Huang, Xin Liang, Yan-Jun Xiang, Qian-Zhi Ni, Zhi-Chao Liu, Qian-Wen Zheng, Yi-Kang Wang, Hui-Jun Cao, Ji Xia, Sheng Xu, Xiao-Song Qiu, Xi-Ran Zhang, Lingyun Long, Zhi-Gang Li, Fan Yao
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-08-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/8/e012044.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma
by: Yu Lian, et al.
Published: (2017-06-01)

PPDPF is not a key regulator of human pancreas development.
by: Markus Breunig, et al.
Published: (2025-04-01)

NEDD4L inhibits cell viability, cell cycle progression, and glutamine metabolism in esophageal squamous cell carcinoma via ubiquitination of c-Myc
by: Cheng Wei, et al.
Published: (2022-05-01)

Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy
by: Jun Yang, et al.
Published: (2023-01-01)

Blocking calcium-MYC regulatory axis inhibits early dedifferentiation of chondrocytes and contributes to cartilage regeneration
by: Xu Wu, et al.
Published: (2025-07-01)

Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma
by: Qi Wang, et al.
Published: (2025-07-01)

QSOX2‐Mediated Disulfide Bond Modification Enhances Tumor Stemness and Chemoresistance by Activating TSC2/mTOR/c‐Myc Feedback Loop in Esophageal Squamous Cell Carcinoma
by: Wo‐Ming Chen, et al.
Published: (2025-08-01)

Clonorchis sinensis-driven hepatocarcinogenesis via E2F1-CD24 transcriptional axis: mechanistic and therapeutic implications
by: Wen-Min Lu, et al.
Published: (2025-08-01)

Multi-cohort validation based on a novel prognostic signature of anoikis for predicting prognosis and immunotherapy response of esophageal squamous cell carcinoma
by: Zhongquan Yi, et al.
Published: (2025-03-01)

c-Myc-dependent LAMP3 regulates the proliferation, metastasis and metabolic reprogramming of tongue squamous cell carcinoma
by: Jing Feng, et al.
Published: (2025-05-01)

Obesity Potentiates Esophageal Squamous Cell Carcinoma Growth and Invasion by AMPK-YAP Pathway
by: Jia-Huang Liu, et al.
Published: (2020-01-01)

Establishing and validating models integrated with hematological biomarkers and clinical characteristics for the prognosis of non-esophageal squamous cell carcinoma patients
by: Ning Xue, et al.
Published: (2025-12-01)

Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis
by: Jing Chen, et al.
Published: (2025-03-01)

PINK1 suppresses malignant phenotypes in esophageal squamous cell carcinoma
by: Xiangyun Lu, et al.
Published: (2025-06-01)

JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis
by: Yuwan Zhao, et al.
Published: (2025-05-01)

Targeting p-FGFR1<sup>Y654</sup> Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis
by: Hong Luo, et al.
Published: (2025-07-01)

First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis
by: Jing-Wen Han, et al.
Published: (2025-01-01)

First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis.
by: Jing-Wen Han, et al.
Published: (2025-01-01)

promoter methylation is associated with prognosis in esophageal squamous cell carcinoma
by: Xiaoying Chen, et al.
Published: (2017-02-01)

The MYC/TXNIP axis mediates NCL-Suppressed CD8+T cell immune response in lung adenocarcinoma
by: Dan Xiao, et al.
Published: (2025-05-01)

AP001885.4 promotes the proliferation of esophageal squamous cell carcinoma cells by histone lactylation- and NF-κB (p65)-dependent transcription activation and METTL3-mediated mRNA stability of c-myc
by: Chuang Fu, et al.
Published: (2024-12-01)

Metabolic state uncovers prognosis insights of esophageal squamous cell carcinoma patients
by: Tingze Feng, et al.
Published: (2025-03-01)

Role of Oral and Esophageal Microbiota in Esophageal Squamous Cell Carcinoma
by: Kong Jinyu, et al.
Published: (2025-07-01)

PP1γ promotes esophageal squamous cell carcinoma progression through the PP1γ/YAP1/SOX2 axis
by: Juan Du, et al.
Published: (2025-06-01)

Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy
by: Zhifu Chen, et al.
Published: (2025-01-01)

HJURP modulates cell proliferation and chemoresistance via the MYC/TOP2A transcriptional axis in gastric cancer
by: Xu Li, et al.
Published: (2025-04-01)

Blocking SLC7A11 attenuates the proliferation of esophageal squamous cell carcinoma cells
by: Wen-Ting Li, et al.
Published: (2024-12-01)

Inhibition of colorectal carcinogenesis by sunitinib malate: disruption of the IL-6/STAT3/c-MYC/TWIST/MMP2 autocrine signaling axis
by: Ling Qian, et al.
Published: (2025-05-01)

ISCU-p53 axis orchestrates macrophage polarization to dictate immunotherapy response in esophageal squamous cell carcinoma
by: Jialiang Luo, et al.
Published: (2025-06-01)

Esophageal squamous cell carcinoma and prognosis in Taiwan
by: Ya‐Fu Cheng, et al.
Published: (2018-09-01)

Expression of kinetochore component NDC80 promotes esophageal squamous cell carcinoma cells proliferation and migration
by: Youwu Shi, et al.
Published: (2025-06-01)

Prognostic significance of the pN classification supplemented by vascular invasion for esophageal squamous cell carcinoma.
by: Chong-Mei Zhu, et al.
Published: (2014-01-01)

Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance
by: Han‐Jie Zhang, et al.
Published: (2021-11-01)

Association between cancer-associated fibroblasts and prognosis of neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a bioinformatics analysis based on single-cell RNA sequencing
by: Zhao Huang, et al.
Published: (2025-03-01)

Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma
by: Min Ma, et al.
Published: (2024-12-01)

Immunotherapy in young adults with mature cystic ovarian Teratoma-Derived squamous cell carcinoma: a case series
by: Jing Luo, et al.
Published: (2025-05-01)

Targeting GPX4 to Induce Ferroptosis Overcomes Chemoresistance Mediated by the PAX8‐AS1/GPX4 Axis in Intrahepatic Cholangiocarcinoma
by: Zhi‐Wen Chen, et al.
Published: (2025-08-01)

High mobility group A1 (HMGA1) promotes esophageal squamous cell carcinoma progression by inhibiting STING-mediated anti-tumor immunity
by: Kai-Yue He, et al.
Published: (2025-06-01)

CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinoma
by: Jun Wang, et al.
Published: (2025-08-01)

The Mural Form of Eosinophilic Esophagitis Is Accompanied by Superficial Esophageal Squamous Cell Carcinoma
by: Zhao Jingsheng, et al.
Published: (2012-01-01)